A SU6668 pure nanoparticle-based eyedrops: toward its high drug Accumulation and Long-time treatment...
A SU6668 pure nanoparticle-based eyedrops: toward its high drug Accumulation and Long-time treatment for corneal neovascularization
About this item
Full title
Author / Creator
Wu, Han , Ye, Jinfa , Zhang, Minjie , Zhang, Lingyu , Lin, Sijie , Li, Qingjian , Liu, Yanbo , Han, Yun , Huang, Caihong , Wu, Yiming , Cheng, Yuhang , Cai, Shundong , Ke, Lang , Liu, Gang , Li, Wei and Chu, Chengchao
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Corneal neovascularization (CNV) is one of the common blinding factors worldwide, leading to reduced vision or even blindness. However, current treatments such as surgical intervention and anti-VEGF agent therapy still have some shortcomings or evoke some adverse effects. Recently, SU6668, an inhibitor targeting angiogenic tyrosine kinases, has dem...
Alternative Titles
Full title
A SU6668 pure nanoparticle-based eyedrops: toward its high drug Accumulation and Long-time treatment for corneal neovascularization
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6b39392b06444606882cbb26dfa9ccdc
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6b39392b06444606882cbb26dfa9ccdc
Other Identifiers
ISSN
1477-3155
E-ISSN
1477-3155
DOI
10.1186/s12951-024-02510-8
